Quick Facts

• Dental Caries: Helps in the prevention of tooth decay.
• Demineralization: May promote the remineralization process of tooth enamel.
• Dental Plaque: Used as part of protocols to manage the formation of bacterial films on teeth.

What Aminfluorid Treats: Main Uses and Benefits

Aminfluorid is indicated for use in the management and prevention of dental caries (tooth decay). Its principal application is as an agent intended to increase the resistance of the tooth surface to acid attacks. Through this process, it may promote the remineralization of enamel that has undergone initial demineralization. The use of this agent is a key component of oral health protocols focused on controlling the progression of tooth decay in both adults and children.

The inclusion of this type of fluoride preparation in regular oral hygiene has been associated with a reduction in the development of new decay. This benefit is achieved through local action on the tooth surface. The substance is also employed to support strategies aimed at reducing the formation of dental plaque and managing cariogenic microorganisms in the oral cavity, which contributes to overall dental stability. This approach supports contemporary standards for caries control. The specific usage should be guided by professional dental recommendations.

Who can and cannot use Aminfluorid?

The eligibility profile for Aminfluorid, which contains Olaflur and Sodium Fluoride, is defined by regulatory guidelines to mitigate the risks associated with systemic fluoride exposure.

Contraindications and Restrictions

The medicine is contraindicated for any individual with a documented hypersensitivity to fluoride or any other component in the formulation. Use is also prohibited in populations where the total systemic fluoride intake, which includes sources such as drinking water, is determined to exceed 0.6 ppm.

Age-Specific Eligibility

Aminfluorid is not recommended for pediatric patients under the age of 6 years. This limitation is based on regulatory findings that safety and effectiveness are not established in this age group, coupled with the specific risk of dental fluorosis resulting from repeated, accidental ingestion of the high-concentration product. Use is generally supported for children and adolescents aged 6 to 16 years, and no specific restrictions are placed on adults or older adults.

Conditional Use Populations

Specific caution is required for certain populations. Patients with severe renal impairment must use the product conditionally due to concerns regarding the excretion and potential systemic accumulation of fluoride. For pregnant women, the medicine holds a U.S. FDA Pregnancy Category B classification, and caution should be exercised when administered to a nursing woman.

Interactions with other medicines and products

Regulatory documentation confirms that the interaction profile of Aminfluorid (Olaflur/Sodium Fluoride) is highly specific due to its topical administration as a cariostatic agent. Documented interactions focus strictly on substances that interfere with the local chemistry and intended efficacy of the product, rather than systemic drug-drug interactions.

Physicochemical and Timing-Based Restrictions

The primary official interaction pattern involves physicochemical interference with polyvalent cations. This mechanism is officially described as the formation of insoluble complexes that prevent the proper local action of the fluoride components on the tooth enamel.

Officially Restricted Substances and Products:

• Medicinal Products: The simultaneous or immediate sequential use of the product with substances that contain calcium, magnesium, or aluminum (such as certain antacids or mineral supplements) is officially restricted.
• Foods and Supplements: The regulatory label mandates a timing-based separation from the ingestion of high-calcium foods, specifically milk and dairy products. This is a required constraint to maintain the product’s therapeutic efficacy.

Systemic Interaction Profile

The official labeling records no documented systemic interactions with other medicines. This includes no documented pharmacokinetic interactions related to CYP enzymes or drug transporters, and no official warnings regarding additive or synergistic systemic pharmacodynamic effects.

Aminfluorid works through the topical action of the fluoride ion (F^-), delivered by both Olaflur and Sodium Fluoride, engaging three complementary mechanisms influencing mineral structure and acid-base equilibrium.

Mineral Modification and Structural Reinforcement

This mechanism focuses on the physicochemical modification of the hard tissues. The F^- ion engages in ionic exchange with the hydroxylapatite mineral in the enamel. This substitution forms fluorapatite, a structurally more stable mineral that reduces the critical pH required for enamel dissolution. This action contributes to the reduced acid solubility of the tooth mineral.

Suppression of Cariogenic Bacterial Metabolism

This domain involves the drug's effect on the plaque biofilm. At low pH, F^- enters cariogenic bacteria cells and acts as an enzyme inhibitor, primarily targeting glycolytic enzymes like enolase. By interfering with this pathway, the drug suppresses the production of destructive acids (e.g., lactic acid), which functionally lowers the frequency and severity of acid exposure.

Surface Dynamics and Fluoride Retention

This mechanism highlights the Olaflur component's synergy. Its cationic surfactant property ensures high affinity and prolonged retention of F^- on the enamel surface. This enables the rapid formation of a protective, acid-sensitive calcium fluoride ( CaF2)-like reservoir. This reservoir is dynamically important because it releases a burst of F^- immediately when the local pH drops, actively promoting remineralization of demineralized zones.

How to use Aminfluorid

Aminfluorid, a topical cariostatic agent containing Olaflur and Sodium Fluoride, is used according to specific instructions to confine its action to the tooth surface and minimize systemic exposure. The administration is strictly by the topical dental route and the product must not be swallowed.

---

Administration Method and Frequency

Use Context	Labeled Dosing Regimen	Frequency & Duration
Home Use (Prescription Gel)	Apply a thin ribbon of gel to the teeth using a toothbrush, in place of regular toothpaste.	Once daily, preferably at bedtime, for at least one minute.
Professional Office Use	Higher concentration formulations are applied by a dental professional using trays or swabs.	Frequency is typically approx twice yearly in a clinical setting, often reserved for patients with elevated caries risk.

---

Procedural and Age Constraints

Procedural constraints ensure optimal contact time and proper handling of the concentrated product:

• Use of the concentrated gel and solution formulations is contraindicated in pediatric patients under age 6 years. This restriction is in place due to the risk of unintentional ingestion resulting from the inability to reliably expectorate the product.
• Following application, adults are instructed to expectorate the gel. Pediatric patients (age 6 and older) should expectorate and rinse thoroughly after use.
• For maximum effect, the user should refrain from eating, drinking, or rinsing their mouth for 30 minutes immediately following application.

The entire usage protocol, including precise dosing and post-application restrictions, defines the standardized, label-based approach for the administration of this formulation.

Research evidence / Overview of studies for Aminfluorid

Evidence for Use in Preventing Dental Caries (Tooth Decay)

Research concerning Aminfluorid was primarily evaluated in studies exploring outcomes related to dental caries. This area was evaluated in multiple study types, including Randomized Controlled Trials (RCTs) and Systematic Reviews. Studies monitored outcomes related to the progression of decay, specifically measuring the incidence of new carious lesions over defined time intervals. These studies were generally conducted in research contexts involving schoolchildren and adolescents.

Research documented patterns observed in the measured incidence of new carious lesions when comparing the preparation against control groups. Studies reported how the measured decay parameters evolved in the observed populations. The evidence contributes to the broader evidence landscape related to dental decay.

What remains uncertain are the patterns observed beyond the conclusion of the research. Long-term outcomes are not fully established, as most published clinical trials typically concluded their follow-up after an intermediate duration of around two to three years.

Studies on Early Enamel Damage (White Spot Lesions)

Research has also explored the relationship between the preparation and initial enamel demineralization, which often appears as white spot lesions. This was mainly evaluated in focused Randomized Controlled Trials (RCTs). The studied populations were typically narrower, often focusing on adolescents undergoing treatment with fixed orthodontic appliances.

Studies reported patterns observed in the development of new demineralization events within the studied group over the treatment period. Research described changes measured during the study period, with findings indicating patterns related to the evolution of these early signs of damage.

Certainty remains low regarding the general applicability of these findings. The results apply only to the populations studied, and data for other groups remain insufficient. This means the research structure provides limited insight into how similar measurements would be observed in the wider general population.

Research on Adjunctive Oral Health Outcomes

Studies examined Aminfluorid and monitored secondary outcomes related to overall oral hygiene, including outcomes linked to inflammatory or irritative states. Studies monitored parameters such as gingival bleeding scores and observed patterns related to the presence of cariogenic microorganisms.

Findings contribute to understanding how patients reported their experience related to oral hygiene. However, the evidence is limited, as these outcomes were generally not the primary focus of the large-scale studies. The findings for these adjunctive outcomes were mixed across studies.

Research Gaps and Areas of Uncertainty

The clinical research for Aminfluorid contains several areas where further investigation is needed. Follow-up durations were limited in many studies, meaning long-term outcomes are not fully established. Comparative evidence for this combination preparation against other available preparations is not consistently provided across all literature.

Furthermore, sample sizes were modest in some of the more specialized trials, and evidence quality varies across studies. Data for certain groups, such as older adults, remain insufficient.

Key Studies & References WHO Collaborating Centre for Drug Statistics Methodology: Anatomical Therapeutic Chemical (ATC) Classification Code A01AA03

Common questions about Aminfluorid (FAQ)

Q: Is Aminfluorid safe for children?

Official regulatory documents state that this product is generally supported for use in children and adolescents aged 6 to 16 years. However, its use is not supported for pediatric patients under 6 years of age, as safety and effectiveness have not been established in this age group. This restriction is primarily due to the specific risk of dental fluorosis (changes in tooth appearance) if the product is repeatedly swallowed during the critical time of tooth development.

Q: Are there any long-term side effects associated with Aminfluorid use?

Studies and official information indicate that long-term outcomes following the use of Aminfluorid are not fully established, as most published clinical trials observed participants over intermediate durations, typically two to three years. For children, official documents note that repeated swallowing during tooth development carries the specific risk of dental fluorosis.

Q: Can I use other dental products (like certain mouthwashes) while using Aminfluorid?

Regulatory documents confirm that the interaction profile of Aminfluorid is focused strictly on local substances that could interfere with its intended action. The use of products that contain polyvalent cations like calcium, magnesium, or aluminum—such as certain antacids or mineral supplements—is officially restricted. This constraint is in place because these substances may form complexes that prevent the proper local action of the fluoride components on the enamel.

Q: Does Aminfluorid have any known interactions with herbal supplements?

According to the official product information, no documented systemic interactions with other medicines, including herbal supplements, are recorded for Aminfluorid. However, the product's efficacy can be reduced by local interference from polyvalent cations, such as calcium or magnesium. The regulatory label mandates a timing-based separation from the ingestion of high-calcium foods and substances containing polyvalent cations to maintain therapeutic efficacy.

Q: Can older adults use Aminfluorid without special concerns?

Official guidelines place no specific restrictions on the use of Aminfluorid for adults, including older adults. However, studies and official information indicate that clinical research data focusing on this specific population group remain insufficient.

Storage and Disposal of Aminfluorid

The official regulatory labeling defines specific conditions that must be met to ensure the product's stability and safe handling.

Mandatory Storage Conditions

The medicine must be stored below 25 C (77 F). The product must be protected from light and it is explicitly stated that the preparation must not be frozen.

To preserve the contents, Aminfluorid must be kept in its original container and the container must remain tightly closed.

Child Safety and Disposal

As with all medicines, Aminfluorid must be stored out of the sight and reach of children.

Disposal of unused or expired product must be managed strictly according to local regulatory requirements. The medicine must not be thrown away via household waste or wastewater to avoid environmental contamination.